Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
11/04/1999 | WO1999055711A1 Treatment of mastitis |
11/04/1999 | WO1999055708A1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action |
11/04/1999 | WO1999055699A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders |
11/04/1999 | WO1999055694A1 Indolyl derivatives as serotonergic agents |
11/04/1999 | WO1999055667A1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
11/04/1999 | WO1999055376A1 Peg-lhrh analog conjugates |
11/04/1999 | WO1999055358A1 Methods for treating hot flashes and gynaecomastia |
11/04/1999 | WO1999055357A1 Method for the treatment of fertility disorders |
11/04/1999 | WO1999055354A1 Fertility improving composition and application thereof |
11/04/1999 | WO1999055333A1 Pharmaceutical imidazole combination for locally treating vulvovaginitis and vaginosis |
11/04/1999 | DE19819023A1 Thienopyrimidine Thienopyrimidines |
11/04/1999 | DE19812204A1 Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung The use of extracts from Cimicifuga racemosa and Belamcanda sinensis estrogenartiges organ-selective drugs without a uterotrophic effect |
11/04/1999 | CA2330448A1 Peg-lhrh analog conjugates |
11/04/1999 | CA2330436A1 Indolyl derivatives as serotonergic agents |
11/04/1999 | CA2330428A1 Treatment of mastitis |
11/04/1999 | CA2329941A1 Methods for treating hot flashes and gynaecomastia |
11/04/1999 | CA2329913A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders |
11/04/1999 | CA2329762A1 Pharmaceutical imidazole combination for locally treating vulvovaginitis and vaginosis |
11/03/1999 | EP0953641A2 Polynucleotide molecules encoding neospora proteins |
11/03/1999 | EP0953570A1 Fluorinated cephalosporin antibiotics and their use for the treatment of mastitis |
11/03/1999 | EP0953568A1 Benzothiophene pharmaceutical compounds |
11/03/1999 | EP0952843A2 Pharmaceutical formulations for sustained drug delivery |
11/03/1999 | EP0744944B1 Sexual steroid-containing transdermal therapeutic systems |
11/03/1999 | CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12) |
11/03/1999 | CN1234026A Piperazino derivatives as neurokinin antagonists |
11/03/1999 | CN1233474A Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections |
11/02/1999 | US5977382 Benzo[b]thiophene compounds, intermediates, processes, compositions, and methods |
11/02/1999 | US5977178 Compounds with growth hormone releasing properties |
11/02/1999 | US5977157 Methods for inhibiting endometriosis |
11/02/1999 | US5977155 Cardiovascular, kidneys |
11/02/1999 | US5977150 Amino acid derivatives of diaryl 1,3,4-oxadiazolone |
11/02/1999 | US5977143 Medicament against infertility which reduces phagocytosis of spermatozoa in women |
11/02/1999 | US5977124 β-adrenergic agonists |
11/02/1999 | US5977115 Alpha 1a adrenergic receptor antagonists |
11/02/1999 | US5977098 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods |
11/02/1999 | US5977068 Parenteral administering |
11/02/1999 | US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor |
11/02/1999 | US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof |
11/02/1999 | US5976545 ZPC polypeptides |
10/28/1999 | WO1999054707A2 Fetal testing for prediction of low birth weight |
10/28/1999 | WO1999054333A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
10/28/1999 | WO1999054284A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
10/28/1999 | WO1999053951A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
10/28/1999 | WO1999053910A2 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
10/28/1999 | WO1999053897A2 Topical formulation comprising poloxamers and further microbicides, and an applicator |
10/28/1999 | WO1999042089A9 Use of thiadiazolo[4,3-a]pyridine derivatives |
10/28/1999 | WO1999040946A3 Methods and compositions for modulating leptin activity |
10/28/1999 | WO1999036063A9 Vanadium (iv) metallocene complexes having spermicidal activity |
10/28/1999 | WO1998040099A9 Leptospira pathogens |
10/28/1999 | CA2328413A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
10/27/1999 | EP0952154A2 N-acyl and N-aroyl aralkyl amides |
10/27/1999 | EP0951908A2 Method of treating impotence due to spinal cord injury |
10/27/1999 | EP0951556A2 Disease associated protein tyrosine phosphatases |
10/27/1999 | CN1233288A GnRH-leukotoxin chimeras |
10/27/1999 | CN1233246A Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors |
10/27/1999 | CN1233181A Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
10/27/1999 | CN1233178A Pyrazolinones to treat disturbances of potency |
10/27/1999 | CN1232702A Mastopathy treating ointment |
10/26/1999 | US5972944 Use of thiazolidinedione derivatives in the treatment of anovulation, hyperandrogenism and hirsutism |
10/26/1999 | US5972940 Arginine analogues having nitric oxide synthase inhibitor activity |
10/26/1999 | US5972935 Psychological disordrs, nervous system disorders, parkinson's disorder |
10/26/1999 | US5972921 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men |
10/26/1999 | US5972898 Erythromycin a derivatives as lutenizing hormone releasing hormone (lhrh) antagonists, and methods of their preparation |
10/26/1999 | US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis |
10/26/1999 | US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease; |
10/26/1999 | US5972377 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
10/26/1999 | CA2183320C Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
10/21/1999 | WO1999053040A2 Human nucleic acid sequences from ovarian tumour tissue |
10/21/1999 | WO1999052907A1 Azabicyclic 5ht1 receptor ligands |
10/21/1999 | WO1999052890A1 Chromanone and thiochromanone derivatives |
10/21/1999 | WO1999052544A2 Regulation of ovarian maturation and function using epidermal growth factor |
10/21/1999 | DE19817557A1 Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe Human nucleic acid sequences from Ovartumorgewebe |
10/21/1999 | CA2327782A1 Azabicyclic 5ht1 receptor ligands |
10/20/1999 | EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
10/20/1999 | EP0767660B1 Methods and formulations for modulating the human sexual response |
10/20/1999 | EP0767659B1 Transdermal administration of oxybutynin |
10/20/1999 | CN1232457A 1,4-heterocyclic metalloprotease inhibitors |
10/20/1999 | CN1232087A Polynucleotide molecules encoding neospora proteins |
10/20/1999 | CN1231924A Compound medicament for treating chronic pelvic inflammation |
10/20/1999 | CN1045777C Tetracyclic derivs. process of preparation and use |
10/20/1999 | CN1045769C Process for preparing sulfurous derivs. of imidazole |
10/20/1999 | CN1045768C Angiotension II antagonists compounds, preparing method and use thereof |
10/19/1999 | US5969134 Cardiovascular disorders, vasoconstriction, hypotensive agents and release of endothelins |
10/19/1999 | US5969120 Dna molecule with synthetically mutated retinoblastoma gene encoding a mutated protein; therapy for a tumor cell with mutation in cyclin gene; antitumor agents |
10/19/1999 | US5968985 Benzoylguanidine derivatives as medicaments |
10/19/1999 | US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists |
10/19/1999 | US5968895 Solid ionic complexes of luteinizing hormone releasing hormone analogues(active peptides) and anionic polymer carriers, also for stable suspensions or dispersions(not microencapsulated), for treatment of prostate cancer |
10/19/1999 | US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
10/19/1999 | US5968519 Antiinflammatory agents or analgesics in mammals |
10/19/1999 | US5968499 Polymeric compounds |
10/16/1999 | CA2269049A1 N-acyl and n-aroyl aralkyl amides |
10/14/1999 | WO1999051732A1 Secreted proteins and polynucleotides encoding them |
10/14/1999 | WO1999051600A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES |
10/14/1999 | WO1999051599A1 Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors |
10/14/1999 | WO1999051597A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands |
10/14/1999 | WO1999051596A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | WO1999051595A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | WO1999051259A2 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
10/14/1999 | WO1999051234A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | WO1999051233A1 Antagonists of gonadotropin releasing hormone |